Levodopa test to predict response of carcinoma of the breast to surgical ablation of endocrine glands.
D000230:Adenocarcinoma / Q000097:blood / Q000601:surgery / Q000628:therapy*; D000328:Adult; D000700:Analgesics / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000097:blood / Q000628:therapy*; D001943:Breast Neoplasms / Q000097:blood / Q000601:surgery / Q000628:therapy*; D004295:Dihydroxyphenylalanine; D005260:Female; D006801:Humans; D007016:Hypophysectomy; D008408:Mastectomy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010053:Ovary / Q000601:surgery; D059408:Pain Management; D011388:Prolactin / Q000097:blood; D011863:Radioimmunoassay
D000700:Analgesics; D004295:Dihydroxyphenylalanine; D011388:Prolactin